Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome.
Saved in:
| Title: | Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome. |
|---|---|
| Authors: | Posey JN; Section of Neonatology, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States.; Cardiovascular Pulmonary Research Laboratories, University of Colorado Anschutz, Aurora, CO, United States., Jordan M; Section of Neonatology, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States.; Cardiovascular Pulmonary Research Laboratories, University of Colorado Anschutz, Aurora, CO, United States., Olsen-Dufour A; School of Medicine, University of Colorado Anschutz, Aurora, CO, United States., Nguyen TN; Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States.; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz, Aurora, CO, United States., Farrell C; Cardiovascular Pulmonary Research Laboratories, University of Colorado Anschutz, Aurora, CO, United States.; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz, Aurora, CO, United States., Lewis CV; Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States.; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz, Aurora, CO, United States., Archambault JL; Section of Neonatology, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States., Sul C; Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States.; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz, Aurora, CO, United States., Colon-Hidalgo D; Cardiovascular Pulmonary Research Laboratories, University of Colorado Anschutz, Aurora, CO, United States.; School of Medicine, University of Colorado Anschutz, Aurora, CO, United States., Nozik ES; Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States.; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz, Aurora, CO, United States., Espinosa JM; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz, Aurora CO, United States.; Department of Pharmacology, University of Colorado Anschutz, Aurora, CO, United States., Sullivan KD; Department of Pharmacology, University of Colorado Anschutz, Aurora, CO, United States.; Section of Developmental Biology, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States., Delaney C; Section of Neonatology, Department of Pediatrics, University of Colorado Anschutz, Aurora, CO, United States.; Cardiovascular Pulmonary Research Laboratories, University of Colorado Anschutz, Aurora, CO, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 22; Vol. 17, pp. 1832057. Date of Electronic Publication: 2026 May 22 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1832057 |
